Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Healthcare Biotechnology Medical Instruments & Supplies
Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the... see more

Recent & Breaking News (TSX:EDT)

Spectral Medical Announces Second Quarter Results and Provides Corporate Update

GlobeNewswire August 10, 2023

Spectral Medical Inc. Announces C$5 Million Bought Deal Convertible Note Financing

GlobeNewswire August 10, 2023

Spectral Medical Announces Tigris Clinical Trial Update

GlobeNewswire July 25, 2023

Spectral Medical Announces the Opening of Three Additional Tigris Clinical Trial Sites

GlobeNewswire July 5, 2023

Spectral Medical Appoints Former FDA Director, Dr. David W. Feigal, Jr., to Its Board of Directors

GlobeNewswire June 27, 2023

Spectral Medical Provides Update on Continued Favorable Tigris Clinical Trial Enrollment

GlobeNewswire June 20, 2023

Spectral Medical Inc. Announces Results of Annual and Special Meeting of Shareholders

GlobeNewswire June 8, 2023

Spectral Medical Provides Update on Favorable Tigris Clinical Trial Enrollment

GlobeNewswire May 30, 2023

Spectral Medical Hosts Successful Investigator Meeting; Expected to Help Bolster Enrollment Activities

GlobeNewswire May 24, 2023

Spectral Medical Announces First Quarter Results and Provides Corporate Update

GlobeNewswire May 12, 2023

Spectral Medical Inc. Announces Director Resignation

GlobeNewswire May 4, 2023

Spectral Medical Announces Positive Results of EUPHAS-2 Clinical Trial Evaluating PMX in Critically Ill Endotoxemic Septic Shock Patients

GlobeNewswire April 18, 2023

Spectral Medical Announces Investor Update Conference Call

GlobeNewswire April 6, 2023

Spectral Medical Announces Fourth Quarter and Fiscal 2022 Results and Provides Corporate Update

GlobeNewswire March 24, 2023

Spectral Medical (TSX:EDT) opening two new clinical trial sites for Toraymyxin study

Caroline Egan  March 9, 2023

Spectral Medical Announces the Opening of Two Additional Tigris Clinical Trial Sites

GlobeNewswire March 9, 2023

Spectral Medical To Present At Microcap Rodeo's Annual Winter Wonderland- Best Ideas Virtual Investor Conference Today

Accesswire February 22, 2023

Spectral Medical Provides Update on Tigris Clinical Trial and Other Business Developments

GlobeNewswire January 12, 2023

Spectral Medical (TSX:EDT) partners with Infomed to accelerate commercialization of its dialysis devices

Shoran Devi December 13, 2022

Spectral Medical Announces Strategic Joint Venture With Infomed to Accelerate Commercialization of Dimi and Sami Dialysis Devices

GlobeNewswire December 13, 2022